Generic drugs online

How to Use This Site

Aviation Note

Military pilots enjoy the expert guidance and surveillance provided by the flight surgeon, but no tightly structured control system exists for their civilian counterparts. However, the need for practical information regarding the possible effects of medicinal drugs on flight performance is the same for pilots in all settings. This section can tell civilian pilots how a particular drug may affect his or her eligibility to fly and when it is advisable or necessary to consult a designated aviation medical examiner or an FAA medical officer.

Occurrence of Unrelated Illness

Some medicines such as "blood thinners" or anticoagulants require careful regulation of daily doses to maintain a constant drug effect within critical limits. In this section of your book, emphasis is given to those illnesses that might affect drug use.

Discontinuation

How and when to stop is often as important as ever starting a medicine in the first place. Unfortunately, this aspect of drug use is often overlooked when a medicine is first discussed. Often, it is mandatory that the patient be fully informed on when to discontinue, when not to discontinue, and precisely how to stop use of the drug. When one medicine is stopped, other drugs being taken at the same time may also need to be adjusted. The doctor who is primarily responsible for your overall management must be kept informed of all the drugs you are taking at a given time.

I believe that the remaining information categories in the Drug Profiles are self-explanatory, but I always welcome your letters and questions. I have also started a web site called medicineinfo and can be reached at www.medicineinfo.com. Section Three, "The Leading Edge," offers what are, in my opinion, medicines that show great promise and are just over the horizon from FDA approval. Some of these medicines may not actually be approved, but they give such significant hope that they're worth consideration. The information may actually let patients facing serious diseases ask to be included in scientific studies and get the medicine prior to actual approval. Section Four is a presentation of drug classes arranged alphabetically by their chemical or therapeutic (generic) class. Because of chemical composition and biological activities, some drugs appear in two or more classes. For example, the drug product with the brand name Diuril will be represented by its genenic name, chlorothiazide, in three drug classes: the Thiazide Diuretics (a chemical classification), the Diuretics (a drug action classification), and the Antihypertensives (a disease-oriented classification).